David Rubinow is a Stress Responses and Cortisol physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 412 publications with 25,463 citations (h-index 85); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Psychiatry profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
David Rubinow, MD, is affiliated with University of North Carolina at Chapel Hill. The public record shows 412 publications with 25,463 citations (h-index 85), centered on Stress Responses and Cortisol, Menstrual Health and Disorders, Menopause: Health Impacts and Treatments. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 2 companies, 7 NIH-funded awards (2008–2026).
- Most recent indexed publication: 2026 · European archives of psychiatry and clinical neuroscience
- Top research focus: Stress Responses and Cortisol
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 240.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder
Sponsor: Pulvinar Neuro, LLC
- Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression
Sponsor: Electromedical Products International, Inc.
- Mechanism of Action of tACS for the Treatment of MDD
Sponsor: University of North Carolina, Chapel Hill
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Sage Therapeutics, LLCProgram year20252 payments$20,000openpaymentsdata.cms.gov ↗
- Sage Therapeutics, Inc.Program year202411 payments$62,179openpaymentsdata.cms.gov ↗
- Sage Therapeutics, Inc.Program year202312 payments$22,764openpaymentsdata.cms.gov ↗
NIH funding
Updated 27 Aug 2026
7 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:
- Postdoctoral Training in Reproductive Mood Disorders
Univ of North Carolina Chapel Hill
FY2026$259,248T32MH093315 - Postdoctoral Training in Reproductive Mood Disorders
Univ of North Carolina Chapel Hill
FY2025$244,638T32MH093315 - Postdoctoral Training in Reproductive Mood Disorders
Univ of North Carolina Chapel Hill
FY2024$259,566T32MH093315
Congress activity
Updated 27 Aug 2026
1 congress contribution (2019) across ENDO per OpenAlex. The most recent:
- SUN-197 Differential Gene Expression in Response to Estradiol Withdrawal in Perimenopausal Depression
ENDO Annual Meeting
ENDO2019Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Sustained benefits of closed-loop transcranial alternating current stimulation (CL-tACS) on depression: a 12-week open-label clinical trial.
European archives of psychiatry and clinical neuroscience
Article2026 - Temporal dynamics of neurobehavioral hormone sensitivity in a scaled-down experimental model of early pregnancy and parturition.
Neuropsychopharmacology
Article2024 - Progesterone and plasma metabolites in women with and in those without premenstrual dysphoric disorder.
Depression and anxiety
Article2018
Most-cited works
by citation count (OpenAlex)- 01Effects of Gonadal Steroids in Women With a History of Postpartum DepressionArticle950 citations2000
- 02
- 03
- 04Postmenopausal Hormone Therapy: An Endocrine Society Scientific StatementArticle679 citations2010
- 05The epidemiology of DSM-III-R bipolar I disorder in a general population surveyArticle605 citations1997
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/david-rubinow-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/david-rubinow-069b7712
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
med.unc.edu/psych
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Mentions by others
where others cite or feature them- Other
news.unchealthcare.org/2018/09/rubinow-to-step-down-as-chair-of-the-department-of-psychiatry
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.unchealthcare.org ↗ - Other
felicitypharma.com/redefining-womens-hormonal-mood-disorders-felicity-pharma-welcomes-dr-david-rubinow
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →felicitypharma.com ↗ - Other
medscape.org/viewarticle/560697
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medscape.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill